In short
T89, also known as Dantonic, is a botanical drug derived from traditional Chinese medicine that has shown potential in treating various conditions. This article explores the ongoing clinical trials investigating T89's efficacy and safety in treating chronic stable angina, acute mountain sickness, and COVID-19. We'll examine the drug's composition, mechanism of action, and the results of several clinical studies.
At a glance
- Drug Composition
- Extracts of Danshen (Radix Salviae Miltiorrhizae) and Sanqi (Radix Notoginseng) with borneol
- Main Conditions Studied
- Chronic stable angina, Acute mountain sickness (AMS), COVID-19
- Key Mechanisms
- Improves oxygen carrying capacity, increases oxygen saturation, reduces organ injury from hypoxia
- Administration
- Oral capsules, typically 150-300mg once or twice daily
- Primary Outcomes Measured
- Exercise duration (angina), LLSS scores (AMS), oxygen saturation levels, clinical symptoms
- Safety Assessment
- Monitoring of adverse events and serious adverse events in all trials
- Trial Phases
- Phase II and III studies ongoing
- Notable Features
- Derived from traditional Chinese medicine, being studied for diverse conditions
What is T89?
T89, also known as Dantonic or Compound Danshen Dripping Pills, is a botanical drug derived from traditional Chinese herbal medicine. It is made from the water extracts of two herbs: Danshen (Radix Salviae Miltiorrhizae) and Sanqi (Radix Notoginseng), with Borneol added to enhance absorption. T89 has been approved for use in several countries, including China, Russia, South Korea, and others, for treating various cardiovascular conditions.
What Conditions Does T89 Treat?
T89 is primarily used to treat and prevent the following conditions:
- Chronic Stable Angina Pectoris: This is a type of chest pain caused by reduced blood flow to the heart, typically occurring during physical activity or stress.
- Acute Mountain Sickness (AMS): A condition that can occur when ascending to high altitudes too quickly, causing symptoms like headache, nausea, and dizziness.
- COVID-19: T89 has been investigated for its potential to improve oxygen saturation and clinical symptoms in patients with COVID-19.
How Does T89 Work?
T89 works through several mechanisms to improve cardiovascular health and address the symptoms of its target conditions:
- Improving blood circulation: T89 helps activate blood circulation and remove blood stasis, which can improve overall cardiovascular function.
- Enhancing oxygen delivery: The drug improves the oxygen-carrying capacity of red blood cells and increases oxygen saturation in the blood.
- Protecting organs: T89 can help reduce damage to major organs like the heart, brain, lung, and kidney caused by hypoxia (low oxygen levels).
- Improving microcirculation: The drug helps prevent microcirculation disorders by inhibiting the reduction of various blood components and adhesion factors.
Clinical Trials and Research
T89 has been the subject of numerous clinical trials to evaluate its safety and efficacy for various conditions:
- Chronic Stable Angina: Multiple phase II and III trials have been conducted to assess T89's effectiveness in treating angina symptoms and improving exercise tolerance.
- Acute Mountain Sickness: Studies have investigated T89's potential to prevent and treat AMS symptoms in people ascending to high altitudes.
- COVID-19: A clinical study was initiated to explore T89's effects on improving oxygen saturation and clinical symptoms in COVID-19 patients.
Dosage and Administration
The dosage of T89 can vary depending on the condition being treated and the specific study protocol. Some common dosages used in clinical trials include:
- For chronic stable angina: 150mg to 300mg taken twice daily.
- For acute mountain sickness prevention: 225mg to 300mg taken twice daily for several days before and during ascent to high altitudes.
- For COVID-19 treatment: 300mg taken three times daily for up to 14 days.
It's important to note that these dosages are based on clinical trials, and the appropriate dosage for an individual patient should be determined by a healthcare provider.
Potential Side Effects and Safety
T89 has been used in China and other countries for many years, with over 2 billion doses prescribed to about 10 million people. While this suggests a generally good safety profile, all medications can have potential side effects. Clinical trials have been conducted to assess the safety and tolerability of T89, including studies in healthy Japanese volunteers.
As with any medication, patients should report any unusual symptoms or side effects to their healthcare provider. Additionally, T89 may interact with other medications, so it's important to inform your doctor about all drugs and supplements you are taking.
Future Research and Potential Uses
Ongoing research is exploring additional potential uses for T89:
- COVID-19 treatment: Further studies may investigate T89's role in managing COVID-19 symptoms and improving outcomes.
- Drug interactions: Research is being conducted to understand how T89 may interact with other medications, particularly those metabolized by certain liver enzymes.
As research continues, our understanding of T89's benefits and potential applications may expand, potentially leading to new treatment options for patients with various cardiovascular and respiratory conditions.